The global automated blood processing equipment market is witnessing remarkable momentum, projected to grow from USD 2.12 billion in 2024 to a substantial USD 4.41 billion by 2034. This growth reflects a CAGR of 7.65% over the forecast period.
At its core, this market encompasses equipment that automates the separation, processing, and preparation of blood components for transfusions or further applications. The systems typically use techniques like centrifugation and component expression into dedicated bags—enhancing sample integrity and reducing manual error.
The rising burden of chronic illnesses, the growing demand from trauma centers and surgeries, and the widespread emphasis on safe blood transfusion practices are collectively shaping the future of this market.
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/download-databook/5772
In 2024, North America led the global market, driven by increasing chronic and blood-related disorders. Innovations integrating AI and IoT technologies into blood processing systems are also a key growth factor in the region.
The Asia Pacific region is expected to grow at the fastest pace through 2034. Key drivers include increasing incidences of chronic illnesses such as diabetes and heart diseases, growing healthcare infrastructure in countries like India and China, and rising awareness about blood donation.
China is emerging as a significant contributor with robust manufacturing capabilities, automation adoption, and increased R&D spending.
Germany is seeing advancements in blood safety through strategic partnerships and government campaigns.
The United Kingdom is witnessing market growth through strong NHS-led initiatives and safe transfusion protocols.
Canada is benefiting from expanding blood collection infrastructure and public investment in healthcare systems.
Get All the Details in Our Solutions – Access Report Preview: https://www.towardshealthcare.com/download-sample/5772
Blood Cell Separators held a significant market share in 2024, driven by their critical role in tissue regeneration, wound healing, and therapeutic research.
Blood Storage Systems are anticipated to record the fastest growth, owing to advances in preservation technology and the increasing need for temperature-controlled storage solutions.
Hemoglobin Analyzers led the accessory equipment category in 2024, supported by rising anemia cases, non-invasive POC devices, and preventive healthcare practices.
Automated Blood Collection Systems are expected to grow fastest due to their efficiency in large-scale blood drives and hospital settings.
Blood Banks dominated in 2024, as they remain pivotal in the processing and supply of safe blood.
Diagnostic Centers are projected to grow at the highest CAGR, reflecting increased routine testing and demand for real-time blood analysis.
Blood Transfusion was the leading application in 2024.
Blood Component Separation is expected to experience the fastest growth, backed by the rising demand for personalized transfusion therapy.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
AI is reshaping the automated blood processing industry. Smart systems are now capable of:
Predicting blood demand trends for better inventory management.
Automating analysis of blood samples, enabling faster and more precise diagnostics.
Assisting in drug development by processing vast molecular datasets.
This fusion of artificial intelligence and robotics is reducing operational inefficiencies and human errors while enhancing reliability and throughput in blood centers.
The growing expansion of blood banks and transfusion centers, combined with emerging AI and robotic integration, opens new doors for innovation. Companies that focus on designing high-precision, autonomous systems are well-positioned to tap into rising global demand.
March 2025: Netherlands-based Vitestro launched Aletta, the world’s first Autonomous Robotic Phlebotomy Device (ARPD), revolutionizing blood collection.
December 2024: Metropolis Healthcare unveiled new blood collection tech focused on enhancing patient comfort.
September 2024: India’s Kriya Medical Technologies introduced the ICHOR Medical Molding System, aiming to produce 250 million blood collection tubes annually.
June 2025: NHS invested £9 million to enhance sickle cell treatment services.
June 2025: MetroHealth collaborated with Cleveland EMS to empower paramedics to deliver blood transfusions on-site.
May 2025: Controversial biotech entrepreneur Elizabeth Holmes was reported to be involved in a novel blood testing machine venture.
December 2024: Ecobank donated over UGX 1.3 billion worth of blood bank equipment to Uganda Blood Transfusion Services.
February 2025: A German hospital partnered with Nigeria’s NBSA and AKTH to boost blood transfusion safety standards.
To access the full Market Report : https://www.towardshealthcare.com/price/5772
The global genomic urine testing market is on a fast growth trajectory. Valued at USD 148.23 million in 2024, the… Read More
The global metagenomics market is poised for robust growth over the next decade, projected to surge from USD 2.36 billion… Read More
The global bacteriophage market is experiencing a significant surge as the world grapples with the growing challenge of antimicrobial resistance… Read More
The laboratory balances and scales market is on a steady growth trajectory, driven by expanding research activities and a surge… Read More
The global gastrointestinal drugs market is experiencing steady growth, expected to rise from USD 40.21 billion in 2024 to USD… Read More
The global low-input sequencing technologies market is experiencing significant momentum and is set for notable growth from 2025 to 2034.… Read More